Docoh
Loading...

151 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
PRPO Precipio Inc
12 Nov 21
Quarterly report
4:02pm
environment. Capitalizing on this strategy, during the end of the third quarter 2020, we transitioned our HemeScreen technology from the R&D facility … and December 31, 2020. Table of Contents LEGAL AND REGULATORY ENVIRONMENT The healthcare industry is subject to numerous laws and regulations
10-Q
2021 Q2
PRPO Precipio Inc
12 Aug 21
Quarterly report
4:07pm
generated technology into a commercial laboratory environment. Capitalizing on this strategy, during the end of the third quarter 2020, we transitioned … in accounts payable within the accompanying condensed consolidated balance sheets at June 30, 2021 and December 31, 2020. LEGAL AND REGULATORY ENVIRONMENT
10-Q
2021 Q1
PRPO Precipio Inc
14 May 21
Quarterly report
4:01pm
laboratory environment. Capitalizing on this strategy, during the end of the third quarter 2020, we transitioned our HemeScreen technology from the R&D … consolidated balance sheets at March 31, 2021 and December 31, 2020. LEGAL AND REGULATORY ENVIRONMENT The healthcare industry is subject to numerous
8-K
EX-1.01
PRPO Precipio Inc
2 Apr 21
Entry into a Material Definitive Agreement
3:00pm
, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment which are applicable … no disposal, discharge, emission or other release of any kind onto such property or into the environment surrounding such property of any toxic or other
424B5
PRPO Precipio Inc
2 Apr 21
Prospectus supplement for primary offering
2:00pm
lab generated technology into a commercial laboratory environment. The Company also holds an exclusive license to patented ICE-COLD-PCR, or ICP … are usually performed in a costly hospital environment; Surgical access: various tumor sites are not always accessible (e.g. brain tumors), in which
10-K
u3o35zcny9m 5hnq
29 Mar 21
Annual report
4:29pm
10-Q
jg0cuess6or3lr
13 Nov 20
Quarterly report
4:01pm
10-Q
dil6xd9d 1f3ohv
13 Aug 20
Quarterly report
3:07pm
424B3
860syz xoz1vlirxg3aq
7 Jul 20
Prospectus supplement
5:27pm
S-1
ne6lwnld afpu3f
26 Jun 20
IPO registration
5:18pm
10-Q
glf5b ex5b3bnqp5atg0
14 May 20
Quarterly report
4:05pm
DEF 14A
640cu3 1rta
29 Apr 20
Definitive proxy
4:32pm
424B3
4iadx
13 Apr 20
Prospectus supplement
4:55pm
S-3/A
fibh1 1q845u3ny
9 Apr 20
Shelf registration (amended)
1:53pm
S-1/A
endj51blte 83d
8 Apr 20
IPO registration (amended)
3:41pm
S-3
6d6yct yo2f7vhfbjkw0
27 Mar 20
Shelf registration
4:51pm
S-1
clji2jfolkh2n
27 Mar 20
IPO registration
4:31pm
8-K
EX-10.1
8amw4x2
27 Mar 20
Entry into a Material Definitive Agreement
4:19pm
10-K
gwpv9yq6 7z
27 Mar 20
Annual report
3:47pm
424B3
f0n778wecp60ts obsi
30 Jan 20
Prospectus supplement
5:09pm